Two studies offer hope that science is turning a corner in fighting Alzheimer’s disease. Dr. Jeffrey Cummings’s annual review of clinical trials reveals important trends in the drug development pipeline. And another study by UNLV’s Nevada Institute of Personalized Medicine shed light on the strong link between certain gut bacteria and the common form of dementia. These interdisciplinary studies demonstrate the immense role research institutions play in advancing human health.